Jupiter Life Line Hospitals Ltd.
•Add ratio to table
ABOUT
AI Sector View
AI GENERATEDHealthcare
This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.
PROS
- Company has delivered good profit growth of 63.1% CAGR over last 5 years
- Company has consistently been profitable over the last 5 years
- Company has delivered good sales growth of 21.0% CAGR over last 5 years
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.06x)
- Company comfortably covers its interest (21.0x coverage)
- Working capital cycle has improved - days down from 195 to 148
CONS
- Receivables are growing faster than sales - a possible quality concern
- Free cash flow has been persistently negative
- Total debt has risen sharply - up 248.0% year on year
- Equity base is being diluted - shares outstanding up 16.0%
- Stock is trading at 5.2x its book value
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | 8960.00 | 61.66 | 128831.05 | 0.22 | 610.40 | 38.41 | 7043.50 | 20.56 | 21.73 | 15.70 |
| MAXHEALTH | 1036.50 | 69.24 | 100883.61 | 0.19 | 322.96 | 4.87 | 2366.17 | 16.70 | 14.97 | 25.29 |
| MANIPALHOS | 729.95 | 107.60 | 96015.96 | 0.00 | 2434.30 | — | 30906.30 | — | 13.93 | 23.83 |
| FORTIS | 911.90 | 65.70 | 68844.63 | 0.11 | 272.80 | 2.26 | 2545.03 | 17.46 | 14.07 | 21.28 |
| ASTERDM | 780.05 | 213.36 | 67994.81 | 0.00 | 29.28 | -68.70 | 1310.68 | 21.60 | 11.46 | 19.53 |
| MEDANTA | 1479.75 | 71.54 | 39786.30 | 0.03 | 157.25 | -1.09 | 1304.05 | 26.50 | 19.38 | 21.99 |
| NH | 1888.80 | 47.30 | 38599.67 | 0.24 | 207.27 | 5.37 | 2683.63 | 78.05 | 16.20 | 17.43 |
| LALPATHLAB | 1919.45 | 59.45 | 32217.74 | 1.07 | 1705.00 | 1172.39 | 7977.00 | 1090.95 | 29.56 | 31.03 |
| KIMS | 764.80 | 157.23 | 32122.10 | 0.00 | 37.40 | -56.00 | 1179.50 | 35.33 | 11.51 | 19.03 |
| AGARWALEYE | 514.20 | 109.87 | 16301.49 | 0.00 | 55.02 | 44.56 | 614.02 | 25.97 | 16.14 | 27.75 |
| VIJAYA | 1496.85 | 82.23 | 15417.21 | 0.13 | 53.10 | 37.61 | 230.98 | 22.83 | 30.28 | 42.66 |
| JLHL | 283.90 | 49.61 | 9307.10 | 0.07 | 375.12 | -14.50 | 4109.83 | 18.23 | 15.70 | 19.29 |
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2,079 | 2,271 | 2,304 | 2,453 | 2,394 | 2,731 | 2,691 | 2,739 | 2,779 | 3,158 | 2,914 | 3,124 | 3,285 | |
| 1,727 | 1,844 | 1,820 | 1,973 | 1,927 | 2,151 | 2,150 | 2,191 | 2,301 | 2,566 | 2,353 | 2,570 | 2,890 | |
| Operating Profit | 352 | 426 | 484 | 480 | 467 | 580 | 542 | 548 | 479 | 592 | 561 | 554 | 395 |
| OPM % | 16.92% | 18.78% | 21.00% | 19.56% | 19.53% | 21.25% | 20.12% | 20.02% | 17.22% | 18.74% | 19.27% | 17.75% | 12.02% |
| 82 | 69 | 81 | 65 | 82 | 93 | 81 | 70 | 129 | 113 | 147 | 78 | 106 | |
| Interest | 82 | 85 | 10 | 9 | 9 | 10 | 27 | 40 | 30 | 30 | 26 | 42 | 81 |
| Depreciation | 78 | 76 | 77 | 75 | 80 | 104 | 106 | 134 | 167 | 167 | 168 | 185 | 216 |
| Profit before Tax | 406 | 480 | 562 | 590 | 550 | 673 | 623 | 618 | 608 | 705 | 598 | 655 | 501 |
| Tax % | 25.03% | 24.79% | 24.80% | 26.89% | 26.08% | 25.26% | 20.83% | 28.06% | 28.73% | 22.53% | 25.91% | 24.93% | 25.79% |
| Net Profit | 304 | 361 | 422 | 431 | 406 | 503 | 493 | 444 | 433 | 546 | 443 | 492 | 372 |
| 5.76 | 6.18 | 6.48 | 6.47 | 6.20 | 7.67 | 7.52 | 6.78 | 6.60 | 8.33 | 6.75 | 7.51 | 5.67 |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 264 | 320 | 399 | 463 | 461 | 657 | 787 | 915 | 1,060 | 1,198 | 12,481 | |
| 203 | 266 | 334 | 382 | 394 | 498 | 583 | 687 | 791 | 899 | 10,379 | |
| Operating Profit | 62 | 54 | 65 | 81 | 68 | 159 | 204 | 227 | 269 | 298 | 2,102 |
| OPM % | 23.31% | 17.02% | 16.25% | 17.58% | 14.64% | 24.17% | 25.91% | 24.85% | 25.40% | 24.91% | 16.84% |
| 3 | 5 | 3 | 3 | 6 | 4 | 11 | 26 | 28 | 40 | 444 | |
| Interest | 8 | 16 | 24 | 26 | 28 | 29 | 28 | 19 | 9 | 13 | 180 |
| Depreciation | 12 | 20 | 24 | 26 | 27 | 28 | 29 | 31 | 42 | 69 | 735 |
| Profit before Tax | 45 | 24 | 20 | 33 | 18 | 106 | 159 | 204 | 246 | 257 | 2,459 |
| Tax % | 34.55% | -25.01% | 8.16% | 9.90% | 5.45% | 19.90% | 32.52% | 25.45% | 25.02% | 25.40% | 24.65% |
| Net Profit | 29 | 30 | 18 | 30 | 17 | 85 | 107 | 152 | 185 | 191 | 1,853 |
| EPS | 5.79 | 5.88 | 3.57 | 5.83 | 3.26 | 16.65 | 18.97 | 23.18 | 28.17 | 29.19 | — |
| Dividend Payout % | 8.64% | 8.50% | 28.04% | 0.00% | 0.00% | 6.01% | 5.27% | 4.31% | 3.55% | 3.43% | — |
COMPOUNDED SALES GROWTH
- 10 Years:
- 17%
- 5 Years:
- 21%
- 3 Years:
- 15%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- 20%
- 5 Years:
- 63%
- 3 Years:
- 21%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- -5%
RETURN ON EQUITY
- 10 Years:
- 16%
- 5 Years:
- 20%
- 3 Years:
- 15%
- Last Year:
- 13%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 51 | 51 | 51 | 51 | 51 | 51 | 57 | 66 | 66 | 66 |
| 120 | 147 | 162 | 186 | 202 | 276 | 409 | 1,180 | 1,357 | 1,542 | |
| 180 | 197 | 241 | 254 | 250 | 319 | 298 | 0 | 137 | 323 | |
| Trade Payables | 28 | 37 | 37 | 59 | 50 | 54 | 62 | 51 | 54 | 73 |
| 41 | 38 | 45 | 44 | 63 | 55 | 60 | 65 | 104 | 157 | |
| Total Liabilities | 420 | 470 | 537 | 594 | 615 | 755 | 885 | 1,361 | 1,718 | 2,160 |
| 246 | 379 | 431 | 435 | 426 | 465 | 476 | 477 | 713 | 1,123 | |
| Capital Work in Progress | 132 | 28 | 12 | 11 | 13 | 14 | 16 | 61 | 163 | 113 |
| 1 | 1 | 2 | 2 | 65 | 71 | 95 | 111 | 606 | 580 | |
| 6 | 10 | 10 | 14 | 12 | 13 | 15 | 17 | 18 | 29 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 46 | 38 | 67 | |
| Cash & Bank | 3 | 4 | 8 | 7 | 19 | 102 | 133 | 297 | 87 | 41 |
| 31 | 48 | 74 | 125 | 79 | 90 | 148 | 351 | 93 | 208 | |
| Total Assets | 420 | 470 | 537 | 594 | 615 | 755 | 885 | 1,361 | 1,718 | 2,160 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 72 | 55 | 60 | 90 | 123 | 151 | 217 | 110 | 219 | 231 | |
| Cash from Investing | -133 | -43 | -58 | -43 | -78 | -69 | -130 | -238 | -455 | -423 |
| Cash from Financing | 68 | 1 | 16 | -32 | -23 | 10 | -23 | 122 | 302 | 145 |
| -3 | 1 | 3 | -1 | 12 | 84 | 31 | -6 | 66 | -47 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
2026-08-07 - Jupiter Life Line Hospitals Limited has informed the Exchange about Transcript
2026-08-03 - Jupiter Life Line Hospitals Limited has informed the Exchange about Copy of Newspaper Publication
2026-08-03 - Jupiter Life Line Hospitals Limited has informed the Exchange about Link of Recording
2026-07-31 - Intimation under Regulation 30(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements Regulations), 2015 ( Listing Regulation )
2026-07-31 - Jupiter Life Line Hospitals Limited has informed the Exchange about Investor Presentation
2026-07-31 - Jupiter Life Line Hospitals Limited has informed the Exchange about Adoption of new line(s) of business
2026-07-31 - Outcome of Board Meeting dated July 31, 2026
2026-07-31 - Jupiter Life Line Hospitals Limited has informed the Exchange regarding Appointment of Mr. Harshad Purani as Chief Financial Officer of the company w.e.f. July 31, 2026.
2026-07-27 - Jupiter Life Line Hospitals Limited has informed the Exchange about Schedule of meet
News
Recent coverage and analyst commentary for JLHL
Loading news…
AI Stock Analyst
Jupiter Life Line Hospitals Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account

